Hemochromatosis gene mutation-Could it be a disease marker for myelodysplasia?

Leukemia Research

Volumn 33, Issue 1, 2009, Pages 201-202

  Varkonyi J ^a   Andrikovics, H ^b   Tordai, A ^b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b Hungarian National Blood Transfusion Service   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

HFE PROTEIN;

CHROMOSOME ABERRATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; DISEASE MARKER; GENE MUTATION; GENETIC ANALYSIS; HEMOCHROMATOSIS; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; KARYOTYPE; LETTER; MYELODYSPLASIA; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL;

HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MEMBRANE PROTEINS; MUTATION; MYELODYSPLASTIC SYNDROMES; TUMOR MARKERS, BIOLOGICAL;

EID: 55049088511     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.03.030     Document Type: Letter

References (9)

1. Lester S., Bardy P., and McCluskey J. HFE genotypes and haemochromatosis: quantifying the risks of disease. Tissue Antigens 54 3 (1999) 282-284
2. Yaounang J., Grobois B., Jounaolle A.M., Goasguen J., and Leblay R. Haemochromatosis Cys282Tyr mutation in pyridoxine-sensitive sideroblastic anaemia. Lancet 349 (1997) 1475-1476
3. Varkonyi J., Tarkovács G., Karádi I., Andrikovics H., Varga F., Varga F., et al. High incidence of hemochromatosis gene mutations in the myelodysplastic syndrome: The Budapest study on 50 patients. Acta Haematol- Basel 109 (2003) 64-67
4. Várkonyi J., Demeter J., Tordai A., and Andrikovics H. The significance of the hemochromatosis genetic variants in multiple myeloma in comparison to that of myelodysplastic syndrome. Ann Hematol 85 (2006) 863-868
5. Várkonyi J., Tordai A., and Andrikovics H. HFE polymorphism and hematological malignancies. International Society of Haematology. Budapest, 29 August-2 September (2007) [Blood Reviews, P084]
6. Speletas M., Kioumi A., Mandala E., Katodritou E., Papaioannou G., Ritis K., et al. Prevalence of hemochromatosis gene (HFE) mutations in Greek patients with myelodysplastic syndromes. Acta Haematol- Basel 110 (2003) 53-54
7. Nearman Z.P., Szpurka H., Serio B., Warshawksy I., Theil K., Lichtin A., et al. Hemochromatosis-associated gene mutations in patients with myelodysplastic syndromes with refractory anemia with ringed sideroblasts. Am J Hematol 82 (2007) 1076-1079
8. Dine G., Genty V., Rehn Y., and Brahimi S. Iron overload MDS and HFE gene mutations: what relation?. Leukemia Res S27 1 (2003) S122
9. Franchin M., and Veneri D. Iron overload and hematological malignancies. Hematol J 5 (2004) 381-438